LEWOO PHARMATECH (SHANGHAI) CO.,LIMITED

Contact Us

Name: Ada Miao
Tel: +86-21-57856308
Mobile: +86-15800805830
E-mail: miao@lewoopharma.com; miaoshuangyu@vip.163.com
Add: Yank Plaza, No.1111, Xinzhen Street, Songjiang District, Shanghai City,China.
WeChat: 15800805830
whatsapp: 15800805830
QQ: 874857614
QQ: 874857614 miao@lewoopharma.com; miaoshuangyu@vip.163.com

Products > Pharmaceutical APIs > ONCOLOGY > Tofacitinib citrate
Tofacitinib citrate
Product name : Tofacitinib citrate
Product No. : 540737-29-9
←[Previous Product]              [Next Product]→
Online Inquiry         Email Us

  Details:
 Torfatib citrate is the first JAK pathway inhibitor with the mechanism of action. It is a novel oral protein tyrosine kinase inhibitor. Since the product was first approved for listing in the United States on November 6, 2012, it has been approved in more than 50 countries and regions around the world such as the United States, Japan, Russia, Australia, Canada, etc.

  Related Products :

Gefitinib
Gefitinib

Erlotinib
Erlotinib

Oxaliplatin
Oxaliplatin

Lapatinib ditosylate
Lapatinib ditosylate

Docetaxel anhydrous
Docetaxel anhydrous

Bortezomib
Bortezomib

Paclitaxel
Paclitaxel

Mitomycin
Mitomycin

Online service

874857614 miao@lewoopharma.com; miaoshuangyu@vip.163.com